Teprotumumab in Thyroid Eye Disease: A Promising Therapeutic Approach

Abstract

Thyroid Eye Disease (TED) is a complex autoimmune inflammatory condition affecting the orbit, and its diagnosis and treatment present unique challenges. Recent research has made significant strides in understanding the underlying causes of TED and identifying effective management strategies. This chapter provides an in-depth look at the exciting potential of Teprotumumab as a treatment for TED, exploring its mechanism of action, clinical efficacy, safety profile, and prospects.